| |
| |
|
| Insider
Information: |
Gallagher Carol Giltner |
| Relationship: |
|
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
702,153 |
|
|
Indirect Shares
|
86,340 |
|
|
| Direct
Value |
$2,059,315 |
|
|
|
Indirect Value
|
$68,952 |
|
|
| Total
Shares |
788,493 |
|
|
| Total
Value |
$2,128,267 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 104.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
|
2024-03-31 |
629,608 |
2015-02-18 |
62,656 |
Premium* |
|
|
Anaptysbio Inc |
ANAB |
Director |
2017-01-31 |
64,296 |
2017-01-31 |
0 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
Director |
2018-12-07 |
8,249 |
2018-12-07 |
23,684 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2023-06-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
50 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRTX |
Mirati Therapeutics, Inc. |
|
• • – |
2024-01-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,363) |
0 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
|
• • – |
2024-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
629,608 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
|
• • – |
2023-11-13 |
4 |
B |
$0.22 |
$40,029 |
D/D |
179,020 |
368,438 |
0.01 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
|
• • – |
2023-11-14 |
4 |
B |
$0.31 |
$28,186 |
D/D |
90,980 |
459,418 |
0.01 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2014-10-21 |
4 |
B |
$11.00 |
$199,991 |
D/D |
18,181 |
51,656 |
2.39 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-06-09 |
4 |
AS |
$13.15 |
$13,150 |
D/D |
(1,000) |
107,374 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-11-16 |
4 |
AS |
$14.20 |
$16,813 |
D/D |
(1,184) |
109,738 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-08-16 |
4 |
AS |
$14.30 |
$16,931 |
D/D |
(1,184) |
108,556 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-05-16 |
4 |
AS |
$15.25 |
$18,056 |
D/D |
(1,184) |
103,374 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2016-05-18 |
4 |
AS |
$15.96 |
$18,897 |
D/D |
(1,184) |
95,462 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-02-16 |
4 |
AS |
$16.10 |
$19,046 |
D/D |
(1,183) |
102,192 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2016-02-17 |
4 |
AS |
$16.30 |
$19,283 |
D/D |
(1,183) |
94,280 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2015-02-18 |
4 |
B |
$18.00 |
$198,000 |
I/I |
11,000 |
62,656 |
2.1 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2016-11-16 |
4 |
AS |
$19.35 |
$22,910 |
D/D |
(1,184) |
99,010 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2015-11-17 |
4 |
AS |
$31.10 |
$36,822 |
D/D |
(1,184) |
93,098 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2018-11-07 |
4 |
S |
$36.38 |
$777,586 |
D/D |
(21,374) |
88,818 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2015-08-24 |
4 |
AS |
$38.44 |
$237,936 |
D/D |
(5,874) |
91,916 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2015-08-21 |
4 |
AS |
$41.65 |
$245,015 |
D/D |
(5,874) |
97,790 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2015-08-20 |
4 |
AS |
$43.24 |
$263,139 |
D/D |
(5,874) |
103,664 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2018-06-18 |
4 |
AS |
$44.68 |
$111,944 |
D/D |
(2,500) |
110,192 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2018-05-16 |
4 |
AS |
$46.06 |
$12,574 |
D/D |
(273) |
111,192 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2018-02-16 |
4 |
AS |
$46.50 |
$55,010 |
D/D |
(1,183) |
110,920 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2015-08-19 |
4 |
AS |
$47.98 |
$283,083 |
D/D |
(5,875) |
109,538 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2015-08-18 |
4 |
AS |
$49.38 |
$284,626 |
D/D |
(5,764) |
115,413 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Director |
– • – |
2023-12-29 |
4 |
A |
$58.75 |
$399,970 |
D/D |
6,808 |
14,363 |
0 |
- |
|
50 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
